University of California, Los Angeles
1,666
216
297
1,018
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.4%
190 terminated/withdrawn out of 1666 trials
84.3%
-2.2% vs industry average
10%
168 trials in Phase 3/4
32%
327 of 1018 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1666)
Skin Change Actions by Nursing
Role: lead
Angiotensin 2 for AKI After OLT
Role: lead
Telerehabilitation and Biomarkers of Recovery After Stroke in Brazil
Role: collaborator
Evaluation of Oral THC and CBD in Men and Women
Role: lead
Inflammation in Methamphetamine and STIs (IMSTI)
Role: lead
Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding
Role: collaborator
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Role: lead
UCLA Magnesium Formulation Athlete Study
Role: lead
Polyphenols and Cognitive Decline
Role: lead
Intervention Trial for Healthcare Workers With Anxiety
Role: lead
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Role: collaborator
Evaluation of "C'Est La Vie!" Digital Health Education
Role: lead
THCV Treatment for Smokers
Role: lead
Telerehabilitation In The Home After Stroke
Role: lead
PRISM Intervention Study
Role: lead
Evaluating tDCS Brain-stimulation in Depression Using MRI
Role: lead
The Fontan Dapagliflozin Pilot Study
Role: collaborator
fNIRS for Disorders of Consciousness
Role: lead
Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo
Role: lead
Brain Networks and Consciousness
Role: collaborator